<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32185393</PMID><DateCompleted><Year>2020</Year><Month>07</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>143</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>Mar</Month><Day>01</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>CYLD is a causative gene for frontotemporal dementia - amyotrophic lateral sclerosis.</ArticleTitle><Pagination><StartPage>783</StartPage><EndPage>799</EndPage><MedlinePgn>783-799</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awaa039</ELocationID><Abstract><AbstractText>Frontotemporal dementia and amyotrophic lateral sclerosis are clinically and pathologically overlapping disorders with shared genetic causes. We previously identified a disease locus on chromosome 16p12.1-q12.2 with genome-wide significant linkage in a large European Australian family with autosomal dominant inheritance of frontotemporal dementia and amyotrophic lateral sclerosis and no mutation in known amyotrophic lateral sclerosis or dementia genes. Here we demonstrate the segregation of a novel missense variant in CYLD (c.2155A&gt;G, p.M719V) within the linkage region as the genetic cause of disease in this family. Immunohistochemical analysis of brain tissue from two CYLD p.M719V mutation carriers showed widespread glial CYLD immunoreactivity. Primary mouse neurons transfected with CYLDM719V exhibited increased cytoplasmic localization of TDP-43 and shortened axons. CYLD encodes a lysine 63 deubiquitinase and CYLD cutaneous syndrome, a skin tumour disorder, is caused by mutations that lead to reduced deubiquitinase activity. In contrast with CYLD cutaneous syndrome-causative mutations, CYLDM719V exhibited significantly increased lysine 63 deubiquitinase activity relative to the wild-type enzyme (paired Wilcoxon signed-rank test P = 0.005). Overexpression of CYLDM719V in HEK293 cells led to more potent inhibition of the cell signalling molecule NF-&#x3ba;B and impairment of autophagosome fusion to lysosomes, a key process in autophagy. Although CYLD mutations appear to be rare, CYLD's interaction with at least three other proteins encoded by frontotemporal dementia and/or amyotrophic lateral sclerosis genes (TBK1, OPTN and SQSTM1) suggests that it may play a central role in the pathogenesis of these disorders. Mutations in several frontotemporal dementia and amyotrophic lateral sclerosis genes, including TBK1, OPTN and SQSTM1, result in a loss of autophagy function. We show here that increased CYLD activity also reduces autophagy function, highlighting the importance of autophagy regulation in the pathogenesis of frontotemporal dementia and amyotrophic lateral sclerosis.</AbstractText><CopyrightInformation>&#xa9; The Author(s) (2020). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dobson-Stone</LastName><ForeName>Carol</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hallupp</LastName><ForeName>Marianne</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shahheydari</LastName><ForeName>Hamideh</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ragagnin</LastName><ForeName>Audrey M G</ForeName><Initials>AMG</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chatterton</LastName><ForeName>Zac</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY 10029 USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carew-Jones</LastName><ForeName>Francine</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shepherd</LastName><ForeName>Claire E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stefen</LastName><ForeName>Holly</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Dementia Research Centre and Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paric</LastName><ForeName>Esmeralda</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Dementia Research Centre and Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fath</LastName><ForeName>Thomas</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Dementia Research Centre and Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Elizabeth M</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>SA Clinical Genetics Service, Women's and Children's Hospital, North Adelaide 5006, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Adelaide Medical School, Faculty of Health Sciences, University of Adelaide, Adelaide SA 5005, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blumbergs</LastName><ForeName>Peter</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Medical and Veterinary Science, Adelaide, SA 5000, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Short</LastName><ForeName>Cathy L</ForeName><Initials>CL</Initials><AffiliationInfo><Affiliation>Department of Neurology, The Queen Elizabeth Hospital, Woodville, SA 5011, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Field</LastName><ForeName>Colin D</ForeName><Initials>CD</Initials><AffiliationInfo><Affiliation>Adelaide Dementia Driving Clinic, Adelaide, SA 5041, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panegyres</LastName><ForeName>Peter K</ForeName><Initials>PK</Initials><AffiliationInfo><Affiliation>Neurodegenerative Disorders Research Pty Ltd, West Perth, WA 6005, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hecker</LastName><ForeName>Jane</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Royal Adelaide Hospital, Adelaide, SA 5000, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nicholson</LastName><ForeName>Garth</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Northcott Neuroscience Laboratory, ANZAC Research Institute, Concord, NSW 2137, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Sydney Medical School, University of Sydney, Camperdown, NSW 2050, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Medicine Laboratory, Concord Hospital, Concord, NSW 2137, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Alex D</ForeName><Initials>AD</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fullerton</LastName><ForeName>Janice M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luty</LastName><ForeName>Agnes A</ForeName><Initials>AA</Initials><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schofield</LastName><ForeName>Peter R</ForeName><Initials>PR</Initials><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brooks</LastName><ForeName>William S</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Prince of Wales Clinical School, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rajan</LastName><ForeName>Neil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, NE1 3BZ, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bennett</LastName><ForeName>Mark F</ForeName><Initials>MF</Initials><AffiliationInfo><Affiliation>Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, VIC 3084, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biology, The University of Melbourne, Parkville, VIC 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bahlo</LastName><ForeName>Melanie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Population Health and Immunity Division, Walter and Eliza Hall Institute of Medical Research, Parkville, VIC 3052, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medical Biology, The University of Melbourne, Parkville, VIC 3052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landers</LastName><ForeName>John E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>University of Massachusetts Medical School, Worcester, MA 01655, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piguet</LastName><ForeName>Olivier</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and School of Psychology, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ARC Centre of Excellence in Cognition and its Disorders, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hodges</LastName><ForeName>John R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>ARC Centre of Excellence in Cognition and its Disorders, Sydney, NSW, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halliday</LastName><ForeName>Glenda M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Topp</LastName><ForeName>Simon D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London SE5 9RX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Bradley N</ForeName><Initials>BN</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London SE5 9RX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>UK Dementia Research Institute, Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, Maurice Wohl Clinical Neuroscience Institute, King's College London, London SE5 9RX, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCann</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fifita</LastName><ForeName>Jennifer A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Kelly L</ForeName><Initials>KL</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atkin</LastName><ForeName>Julie D</ForeName><Initials>JD</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW 2109, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, Bundoora, VIC 3083, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blair</LastName><ForeName>Ian P</ForeName><Initials>IP</Initials><AffiliationInfo><Affiliation>Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, North Ryde, NSW 2109, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kwok</LastName><ForeName>John B</ForeName><Initials>JB</Initials><AffiliationInfo><Affiliation>The University of Sydney, Brain and Mind Centre and Central Clinical School, Faculty of Medicine and Health, Camperdown, NSW 2006, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Neuroscience Research Australia, Randwick, NSW 2031, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>100935/Z/13/Z</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>WT097163MA</GrantID><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>SMITH/APR16/847-791</GrantID><Acronym>MNDA_</Acronym><Agency>Motor Neurone Disease Association</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>MRF_MRF-060-0003-RG-SMITH</GrantID><Acronym>MRF</Acronym><Agency>MRF</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS073873</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Acronym>WT_</Acronym><Agency>Wellcome Trust</Agency><Country>United Kingdom</Country></Grant><Grant><GrantID>R01 NS065847</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><Agency> Department of Health [UK]</Agency><Country>International</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D052060">Research Support, N.I.H., Intramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D004268">DNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C578077">TDP-43 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="C409984">CYLD protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D000074749">Deubiquitinating Enzyme CYLD</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.19.12</RegistryNumber><NameOfSubstance UI="D000072017">Deubiquitinating Enzymes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Brain. 2020 Aug 1;143(8):e68</RefSource><PMID Version="1">32666099</PMID></CommentsCorrections><CommentsCorrections RefType="CommentIn"><RefSource>Brain. 2020 Aug 1;143(8):e67</RefSource><PMID Version="1">32666117</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071182" MajorTopicYN="N">Autophagosomes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001369" MajorTopicYN="N">Axons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001921" MajorTopicYN="N">Brain</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004268" MajorTopicYN="N">DNA-Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074749" MajorTopicYN="N">Deubiquitinating Enzyme CYLD</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072017" MajorTopicYN="N">Deubiquitinating Enzymes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName><QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D061251" MajorTopicYN="N">Primary Cell Culture</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014162" MajorTopicYN="N">Transfection</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CYLD</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">deubiquitinase</Keyword><Keyword MajorTopicYN="N">genome-wide linkage analysis</Keyword><Keyword MajorTopicYN="N">whole-exome sequencing</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2019</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2019</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>7</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>3</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32185393</ArticleId><ArticleId IdType="pmc">PMC7089666</ArticleId><ArticleId IdType="doi">10.1093/brain/awaa039</ArticleId><ArticleId IdType="pii">5809083</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Abalkhail H, Mitchell J, Habgood J, Orrell R, de Belleroche J.. A new familial amyotrophic lateral sclerosis locus on chromosome 16q12.1-16q12.2. Am J Hum Genet 2003; 73: 383&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1180375</ArticleId><ArticleId IdType="pubmed">12830400</ArticleId></ArticleIdList></Reference><Reference><Citation>Abecasis GR, Cherny SS, Cookson WO, Cardon LR.. Merlin&#x2013;rapid analysis of dense genetic maps using sparse gene flow trees. Nat Genet 2002; 30: 97&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pubmed">11731797</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrmoff MD, Magalhes PJ, Ram SJ.. Image processing with ImageJ. Biophotonics Int 2004; 11: 36&#x2013;42.</Citation></Reference><Reference><Citation>Al-Sarraj S, King A, Troakes C, Smith B, Maekawa S, Bodi I, et al.p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol 2011; 122: 691&#x2013;702.</Citation><ArticleIdList><ArticleId IdType="pubmed">22101323</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S, Maillard C, Itin P, Hohl D, Huber M.. Five new CYLD mutations in skin appendage tumors and evidence that aspartic acid 681 in CYLD is essential for deubiquitinase activity. J Invest Dermatol 2008; 128: 587&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">17851586</ArticleId></ArticleIdList></Reference><Reference><Citation>Bajwa DS, Nasr B, Carmichael AJ, Rajan N.. Milia: a useful clinical marker of CYLD mutation carrier status. Clin Exp Dermatol 2018; 43: 193&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">29023940</ArticleId></ArticleIdList></Reference><Reference><Citation>Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, Lindholm C, et al.Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006; 442: 916&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16862116</ArticleId></ArticleIdList></Reference><Reference><Citation>Bignell GR, Warren W, Seal S, Takahashi M, Rapley E, Barfoot R, et al.Identification of the familial cylindromatosis tumour-suppressor gene. Nat Genet 2000; 25: 160&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">10835629</ArticleId></ArticleIdList></Reference><Reference><Citation>Blake PW, Toro JR.. Update of cylindromatosis gene (CYLD) mutations in Brooke-Spiegler syndrome: novel insights into the role of deubiquitination in cell signaling. Hum Mutat 2009; 30: 1025&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3243308</ArticleId><ArticleId IdType="pubmed">19462465</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandmeir NJ, Geser F, Kwong LK, Zimmerman E, Qian J, Lee VM, et al.Severe subcortical TDP-43 pathology in sporadic frontotemporal lobar degeneration with motor neuron disease. Acta Neuropathol 2008; 115: 123&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">18004574</ArticleId></ArticleIdList></Reference><Reference><Citation>Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000; 1: 293&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11464847</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen K, Wallis JW, McLellan MD, Larson DE, Kalicki JM, Pohl CS, et al.BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat Methods 2009; 6: 677&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3661775</ArticleId><ArticleId IdType="pubmed">19668202</ArticleId></ArticleIdList></Reference><Reference><Citation>Cirulli ET, Lasseigne BN, Petrovski S, Sapp PC, Dion PA, Leblond CS, et al.Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways. Science 2015; 347: 1436&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4437632</ArticleId><ArticleId IdType="pubmed">25700176</ArticleId></ArticleIdList></Reference><Reference><Citation>Danilenko M, Stamp E, Stocken DD, Husain A, Zangarini M, Cranston A, et al.Targeting tropomyosin receptor kinase in cutaneous CYLD defective tumors with pegcantratinib: the TRAC randomized clinical trial. JAMA Dermatol 2018; 154: 913&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6128505</ArticleId><ArticleId IdType="pubmed">29955768</ArticleId></ArticleIdList></Reference><Reference><Citation>Dashnow H, Lek M, Phipson B, Halman A, Sadedin S, Lonsdale A, et al.STRetch: detecting and discovering pathogenic short tandem repeat expansions. Genome Biol 2018; 19: 121.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6102892</ArticleId><ArticleId IdType="pubmed">30129428</ArticleId></ArticleIdList></Reference><Reference><Citation>DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, et al.Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011; 72: 245&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3202986</ArticleId><ArticleId IdType="pubmed">21944778</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Z, Sheehan P, Chen S, Yue Z.. Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease? Mol Neurodegener 2017; 12: 90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5746010</ArticleId><ArticleId IdType="pubmed">29282133</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson-Stone C, Luty AA, Thompson EM, Blumbergs P, Brooks WS, Short CL, et al.Frontotemporal dementia-amyotrophic lateral sclerosis syndrome locus on chromosome 16p12.1-q12.2: genetic, clinical and neuropathological analysis. Acta Neuropathol 2013; 125: 523&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3611035</ArticleId><ArticleId IdType="pubmed">23338750</ArticleId></ArticleIdList></Reference><Reference><Citation>Dosemeci A, Thein S, Yang Y, Reese TS, Tao-Cheng JH.. CYLD, a deubiquitinase specific for lysine63-linked polyubiquitins, accumulates at the postsynaptic density in an activity-dependent manner. Biochem Biophys Res Commun 2013; 430: 245&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3545086</ArticleId><ArticleId IdType="pubmed">23146630</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W, Guo Y, Jiang H, Yu X, Li C.. MG132 enhances neurite outgrowth in neurons overexpressing mutant TAR DNA-binding protein-43 via increase of HO-1. Brain Res 2011; 1397: 1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">21620381</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans CS, Holzbaur ELF.. Autophagy and mitophagy in ALS. Neurobiol Dis 2019; 122: 35&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6366665</ArticleId><ArticleId IdType="pubmed">29981842</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F, Yan J, Vemula SP, Liu E, Yang Y, Chen W, et al.SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch Neurol 2011; 68: 1440&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">22084127</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, et al.Frontotemporal dementia and its subtypes: a genome-wide association study. Lancet Neurol 2014; 13: 686&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4112126</ArticleId><ArticleId IdType="pubmed">24943344</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A, Wieland T, Richter B, Ruf W, Schaeffer V, Muller K, et al.Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat Neurosci 2015; 18: 631&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman CS, O&#x2019;Donnell MA, Legarda-Addison D, Ng A, Cardenas WB, Yount JS, et al.The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 2008; 9: 930&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2529351</ArticleId><ArticleId IdType="pubmed">18636086</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganjam GK, Terpolilli NA, Diemert S, Eisenbach I, Hoffmann L, Reuther C, et al.Cylindromatosis mediates neuronal cell death in vitro and in vivo. Cell Death Differ 2018; 25: 1394&#x2013;407.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6113218</ArticleId><ArticleId IdType="pubmed">29352268</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldman JS, Farmer JM, Wood EM, Johnson JK, Boxer A, Neuhaus J, et al.Comparison of family histories in FTLD subtypes and related tauopathies. Neurology 2005; 65: 1817&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16344531</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo MH, Plummer L, Chan YM, Hirschhorn JN, Lippincott MF.. Burden testing of rare variants identified through exome sequencing via publicly available control data. Am J Hum Genet 2018; 103: 522&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6174288</ArticleId><ArticleId IdType="pubmed">30269813</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurzau AD, Chen K, Xue S, Dai W, Lucet IS, Ly TTN, et al.FSHD2- and BAMS-associated mutations confer opposing effects on SMCHD1 function. J Biol Chem 2018; 293: 9841&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6016475</ArticleId><ArticleId IdType="pubmed">29748383</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutierrez H, Davies AM.. Regulation of neural process growth, elaboration and structural plasticity by NF-kappaB. Trends Neurosci 2011; 34: 316&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3115056</ArticleId><ArticleId IdType="pubmed">21459462</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch-Reinshagen V, Pottier C, Nicholson AM, Baker M, Hsiung GR, Krieger C, et al.Clinical and neuropathological features of ALS/FTD with TIA1 mutations. Acta Neuropathol Commun 2017; 5: 96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5719900</ArticleId><ArticleId IdType="pubmed">29216908</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al.Association of missense and 5&#x2019;-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393: 702&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">9641683</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin C, Kim S, Kang H, Yun KN, Lee Y, Zhang Y, et al.Shank3 regulates striatal synaptic abundance of Cyld, a deubiquitinase specific for Lys63-linked polyubiquitin chains. J Neurochem 2019; 150: 776&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">31215654</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin W, Chang M, Paul EM, Babu G, Lee AJ, Reiley W, et al.Deubiquitinating enzyme CYLD negatively regulates RANK signaling and osteoclastogenesis in mice. J Clin Invest 2008; 118: 1858&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2276399</ArticleId><ArticleId IdType="pubmed">18382763</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim G, Bolbolan K, Shahidehpour R, Jamshidi P, Gefen T, Ayala IA, et al.Morphology and distribution of TDP-43 pre-inclusions in primary progressive aphasia. J Neuropathol Exp Neurol 2019; 78: 229&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6380320</ArticleId><ArticleId IdType="pubmed">30753613</ArticleId></ArticleIdList></Reference><Reference><Citation>Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, et al.Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 2016; 12: 1&#x2013;222.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835977</ArticleId><ArticleId IdType="pubmed">26799652</ArticleId></ArticleIdList></Reference><Reference><Citation>Komander D, Lord CJ, Scheel H, Swift S, Hofmann K, Ashworth A, et al.The structure of the CYLD USP domain explains its specificity for Lys63-linked polyubiquitin and reveals a B box module. Mol Cell 2008; 29: 451&#x2013;64.</Citation><ArticleIdList><ArticleId IdType="pubmed">18313383</ArticleId></ArticleIdList></Reference><Reference><Citation>Koriath CA, Bocchetta M, Brotherhood E, Woollacott IO, Norsworthy P, Simon-Sanchez J, et al.The clinical, neuroanatomical, and neuropathologic phenotype of TBK1-associated frontotemporal dementia: a longitudinal case report. Alzheimers Dement (Amst) 2017; 6: 75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5312484</ArticleId><ArticleId IdType="pubmed">28229125</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamark T, Svenning S, Johansen T.. Regulation of selective autophagy: the p62/SQSTM1 paradigm. Essays Biochem 2017; 61: 609&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">29233872</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A, Rayner SL, Gwee SSL, De Luca A, Shahheydari H, Sundaramoorthy V, et al.Pathogenic mutation in the ALS/FTD gene, CCNF, causes elevated Lys48-linked ubiquitylation and defective autophagy. Cell Mol Life Sci 2018; 75: 335&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pubmed">28852778</ArticleId></ArticleIdList></Reference><Reference><Citation>Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al.Analysis of protein-coding genetic variation in 60,706 humans. Nature 2016; 536: 285&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5018207</ArticleId><ArticleId IdType="pubmed">27535533</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo P, Hodges JR.. Frontotemporal dementia and motor neurone disease: overlapping clinic-pathological disorders. J Clin Neurosci 2009; 16: 1131&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">19556136</ArticleId></ArticleIdList></Reference><Reference><Citation>Lork M, Kreike M, Staal J, Beyaert R.. Importance of validating antibodies and small compound inhibitors using genetic knockout studies-T cell receptor-induced CYLD phosphorylation by IKKepsilon/TBK1 as a case study. Front Cell Dev Biol 2018; 6: 40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5932415</ArticleId><ArticleId IdType="pubmed">29755980</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Q, Ruan H, Peng L, Zhang M, Gack MU, Yao WD.. Proteasome-independent polyubiquitin linkage regulates synapse scaffolding, efficacy, and plasticity. Proc Natl Acad Sci USA 2017; 114: E8760&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5642675</ArticleId><ArticleId IdType="pubmed">28973854</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Nicholson AM, Sarkar M, Messing J, Purice MD, Pottier C, et al.TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron 2017; 95: 808&#x2013;16.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Markovinovic A, Cimbro R, Ljutic T, Kriz J, Rogelj B, Munitic I.. Optineurin in amyotrophic lateral sclerosis: multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms. Prog Neurobiol 2017; 154: 1&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pubmed">28456633</ArticleId></ArticleIdList></Reference><Reference><Citation>Maruyama H, Morino H, Ito H, Izumi Y, Kato H, Watanabe Y, et al.Mutations of optineurin in amyotrophic lateral sclerosis. Nature 2010; 465: 223&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">20428114</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore AS, Holzbaur EL.. Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy. Proc Natl Acad Sci USA 2016; 113: E3349&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4914160</ArticleId><ArticleId IdType="pubmed">27247382</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori F, Tanji K, Zhang HX, Nishihira Y, Tan CF, Takahashi H, et al.Maturation process of TDP-43-positive neuronal cytoplasmic inclusions in amyotrophic lateral sclerosis with and without dementia. Acta Neuropathol 2008; 116: 193&#x2013;203.</Citation><ArticleIdList><ArticleId IdType="pubmed">18560845</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#x2019;Diaye EN, Kajihara KK, Hsieh I, Morisaki H, Debnath J, Brown EJ.. PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. EMBO Rep 2009; 10: 173&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2637314</ArticleId><ArticleId IdType="pubmed">19148225</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagabhushana A, Bansal M, Swarup G.. Optineurin is required for CYLD-dependent inhibition of TNFalpha-induced NF-kappaB activation. PLoS One 2011; 6: e17477.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3049778</ArticleId><ArticleId IdType="pubmed">21408173</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy N, Farkas K, Kemeny L, Szell M.. Phenotype-genotype correlations for clinical variants caused by CYLD mutations. Eur J Med Genet 2015; 58: 271&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25782638</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al.Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314: 130&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicolas A, Kenna KP, Renton AE, Ticozzi N, Faghri F, Chia R, et al.Genome-wide Analyses Identify KIF5A as a Novel ALS Gene. Neuron 2018; 97: 1268&#x2013;83.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5867896</ArticleId><ArticleId IdType="pubmed">29566793</ArticleId></ArticleIdList></Reference><Reference><Citation>Oakes JA, Davies MC, Collins MO.. TBK1: a new player in ALS linking autophagy and neuroinflammation. Mol Brain 2017; 10: 5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5288885</ArticleId><ArticleId IdType="pubmed">28148298</ArticleId></ArticleIdList></Reference><Reference><Citation>Pilli M, Arko-Mensah J, Ponpuak M, Roberts E, Master S, Mandell MA, et al.TBK-1 promotes autophagy-mediated antimicrobial defense by controlling autophagosome maturation. Immunity 2012; 37: 223&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3428731</ArticleId><ArticleId IdType="pubmed">22921120</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C, Bieniek KF, Finch N, van de Vorst M, Baker M, Perkersen R, et al.Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol 2015; 130: 77&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4470809</ArticleId><ArticleId IdType="pubmed">25943890</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C, Ravenscroft TA, Sanchez-Contreras M, Rademakers R.. Genetics of FTLD: overview and what else we can expect from genetic studies. J Neurochem 2016; 138 (Suppl 1): 32&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">27009575</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan N, Ashworth A.. Inherited cylindromas: lessons from a rare tumour. Lancet Oncol 2015; 16: e460&#x2013;e9.</Citation><ArticleIdList><ArticleId IdType="pubmed">26370355</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajan N, Langtry JA, Ashworth A, Roberts C, Chapman P, Burn J, et al.Tumor mapping in 2 large multigenerational families with CYLD mutations: implications for disease management and tumor induction. Arch Dermatol 2009; 145: 1277&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2935681</ArticleId><ArticleId IdType="pubmed">19917957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratnavalli E, Brayne C, Dawson K, Hodges JR.. The prevalence of frontotemporal dementia. Neurology 2002; 58: 1615&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">12058088</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton AE, Majounie E, Waite A, Simon-Sanchez J, Rollinson S, Gibbs JR, et al.A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011; 72: 257&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritson GP, Custer SK, Freibaum BD, Guinto JB, Geffel D, Moore J, et al.TDP-43 mediates degeneration in a novel Drosophila model of disease caused by mutations in VCP/p97. J Neurosci 2010; 30: 7729&#x2013;39.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2890254</ArticleId><ArticleId IdType="pubmed">20519548</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruddy DM, Parton MJ, Al-Chalabi A, Lewis CM, Vance C, Smith BN, et al.Two families with familial amyotrophic lateral sclerosis are linked to a novel locus on chromosome 16q. Am J Hum Genet 2003; 73: 390&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1180376</ArticleId><ArticleId IdType="pubmed">12840784</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelaar H, Rohrer JD, Pijnenburg YA, Fox NC, van Swieten JC.. Clinical, genetic and pathological heterogeneity of frontotemporal dementia: a review. J Neurol Neurosurg Psychiatry 2011; 82: 476&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">20971753</ArticleId></ArticleIdList></Reference><Reference><Citation>Soo KY, Sultana J, King AE, Atkinson R, Warraich ST, Sundaramoorthy V, et al.ALS-associated mutant FUS inhibits macroautophagy which is restored by overexpression of Rab1. Cell Death Discov 2015; 1: 15030.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4979432</ArticleId><ArticleId IdType="pubmed">27551461</ArticleId></ArticleIdList></Reference><Reference><Citation>Takeuchi H, Kobayashi Y, Yoshihara T, Niwa J, Doyu M, Ohtsuka K, et al.Hsp70 and Hsp40 improve neurite outgrowth and suppress intracytoplasmic aggregate formation in cultured neuronal cells expressing mutant SOD1. Brain Res 2002; 949: 11&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">12213295</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka Y, Nonaka T, Suzuki G, Kametani F, Hasegawa M.. Gain-of-function profilin 1 mutations linked to familial amyotrophic lateral sclerosis cause seed-dependent intracellular TDP-43 aggregation. Hum Mol Genet 2016; 25: 1420&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">26908597</ArticleId></ArticleIdList></Reference><Reference><Citation>Tankard RM, Bennett MF, Degorski P, Delatycki MB, Lockhart PJ, Bahlo M.. Detecting tandem repeat expansions in cohorts sequenced with short-read sequencing data. Am J Hum Genet 2018; 103: 858&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6288141</ArticleId><ArticleId IdType="pubmed">30503517</ArticleId></ArticleIdList></Reference><Reference><Citation>Teyssou E, Takeda T, Lebon V, Boillee S, Doukoure B, Bataillon G, et al.Mutations in SQSTM1 encoding p62 in amyotrophic lateral sclerosis: genetics and neuropathology. Acta Neuropathol 2013; 125: 511&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">23417734</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorvaldsdottir H, Robinson JT, Mesirov JP.. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 2013; 14: 178&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3603213</ArticleId><ArticleId IdType="pubmed">22517427</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi VB, Baskaran P, Shaw CE, Guthrie S.. Tar DNA-binding protein-43 (TDP-43) regulates axon growth in vitro and in vivo. Neurobiol Dis 2014; 65: 25&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3988849</ArticleId><ArticleId IdType="pubmed">24423647</ArticleId></ArticleIdList></Reference><Reference><Citation>Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, Mosialos G.. CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 2003; 424: 793&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">12917689</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J, Gijselinck I, Van Mossevelde S, Perrone F, Dillen L, Heeman B, et al.TBK1 mutation spectrum in an extended European patient cohort with frontotemporal dementia and amyotrophic lateral sclerosis. Hum Mutat 2017; 38: 297&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5324646</ArticleId><ArticleId IdType="pubmed">28008748</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Mossevelde S, van der Zee J, Gijselinck I, Engelborghs S, Sieben A, Van Langenhove T, et al.Clinical features of TBK1 carriers compared with C9orf72, GRN and non-mutation carriers in a Belgian cohort. Brain 2016; 139: 452&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4805085</ArticleId><ArticleId IdType="pubmed">26674655</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF, et al.PennCNV: an integrated hidden Markov model designed for high-resolution copy number variation detection in whole-genome SNP genotyping data. Genome Res 2007; 17: 1665&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2045149</ArticleId><ArticleId IdType="pubmed">17921354</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang PY, Chang KT, Lin YM, Kuo TY, Wang GS.. Ubiquitination of MBNL1 Is required for its cytoplasmic localization and function in promoting neurite outgrowth. Cell Rep 2018; 22: 2294&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">29490267</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts GD, Wymer J, Kovach MJ, Mehta SG, Mumm S, Darvish D, et al.Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 2004; 36: 377&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">15034582</ArticleId></ArticleIdList></Reference><Reference><Citation>Webster CP, Smith EF, Bauer CS, Moller A, Hautbergue GM, Ferraiuolo L, et al.The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy. EMBO J 2016; 35: 1656&#x2013;76.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4969571</ArticleId><ArticleId IdType="pubmed">27334615</ArticleId></ArticleIdList></Reference><Reference><Citation>Wild P, Farhan H, McEwan DG, Wagner S, Rogov VV, Brady NR, et al.Phosphorylation of the autophagy receptor optineurin restricts Salmonella growth. Science 2011; 333: 228&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3714538</ArticleId><ArticleId IdType="pubmed">21617041</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams KL, Topp S, Yang S, Smith B, Fifita JA, Warraich ST, et al.CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat Commun 2016; 7: 11253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4835537</ArticleId><ArticleId IdType="pubmed">27080313</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo JA, Liu T, Trotter C, Fang CC, De Narvaez E, LePochat P, et al.Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity. Nat Commun 2017; 8: 15558.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5467170</ArticleId><ArticleId IdType="pubmed">28585542</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu CH, Fallini C, Ticozzi N, Keagle PJ, Sapp PC, Piotrowska K, et al.Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis. Nature 2012; 488: 499&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3575525</ArticleId><ArticleId IdType="pubmed">22801503</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang M, Wu X, Lee AJ, Jin W, Chang M, Wright A, et al.Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J Biol Chem 2008; 283: 18621&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2441564</ArticleId><ArticleId IdType="pubmed">18467330</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>